Filing Details

Accession Number:
0001683168-18-000125
Form Type:
13G Filing
Publication Date:
2018-01-12 18:01:13
Filed By:
Lvp Life Science Ventures Iii L.p.
Company:
Evoke Pharma Inc (NASDAQ:EVOK)
Filing Date:
2018-01-16
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
LVP Life Science Ventures III 1,472,867 1,583,329 1,472,867 1,583,329 1,472,867 9.56%
LVP III Associates 73,641 73,641 73,641 0.48%
LVP III Partners 36,821 36,821 36,821 0.24%
LVP GP III 1,583,329 1,583,329 1,583,329 10.28%
LVPMC 5,250 5,250 5,250 0.02%
Patrick F. Latterell ( Latterell ) 5,250 5,250 1,588,579 10.28%
Filing

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Schedule 13G
(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)

 

(Amendment No. 1)*

 

 

Evoke Pharma, Inc.

 

(Name of Issuer)

 

Common Stock

 

(Title of Class of Securities)

 

30049G104

 

(CUSIP Number)

 

December 31, 2017

 

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

[_]Rule 13d-1(b)

[_]Rule 13d-1(c)

[X]Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(Continued on following pages)

 

Page 1 of 12

 

Exhibit Index on Page 11

 

 

   

 

CUSIP #30049G104 Page 2 of 12

 

1

NAME OF REPORTING PERSONS

 

LVP Life Science Ventures III, L.P. (“LVP III”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) [_] (b) [X]

3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH
5

SOLE VOTING POWER
1,472,867 shares, except that LVP GP III, LLC (“GP III”), the general partner of LVP III, may be deemed to have sole power to vote these shares, and Patrick Latterell (“Latterell”), the managing member of GP III, may be deemed to have shared power to vote these shares.

 

6

SHARED VOTING POWER
See response to row 5.

 

7

SOLE DISPOSITIVE POWER
1,472,867 shares, except that GP III, the general partner of LVP III, may be deemed to have sole power to dispose of these shares, and Latterell, the managing member of GP III, may be deemed to have shared power to dispose of these shares.

 

8

SHARED DISPOSITIVE POWER
See response to row 7.

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,472,867

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES

 [_]

11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.56%
12

TYPE OF REPORTING PERSON

PN

       
 

 

CUSIP #30049G104 Page 3 of 12

 

1

NAME OF REPORTING PERSONS

LVP III Associates, L.P. (“Associates”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) [_] (b) [X]

3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH
5

SOLE VOTING POWER
73,641 shares, except that GP III, the general partner of Associates, may be deemed to have sole power to vote these shares, and Latterell, the managing member of GP III, may be deemed to have shared power to vote these shares.

 

6

SHARED VOTING POWER
See response to row 5.

 

7

SOLE DISPOSITIVE POWER
73,641 shares, except that GP III, the general partner of Associates, may be deemed to have sole power to dispose of these shares, and Latterell, the managing member of GP III, may be deemed to have shared power to dispose of these shares.

 

8

SHARED DISPOSITIVE POWER
See response to row 7.

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

73,641

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 [_]

11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.48%
12

TYPE OF REPORTING PERSON

PN

       

 

 

 

CUSIP #30049G104 Page 4 of 12

 

1

NAME OF REPORTING PERSONS

LVP III Partners, L.P. (“Partners”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) [_] (b) [X]

3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH
5

SOLE VOTING POWER
36,821 shares, except that GP III, the general partner of Partners, may be deemed to have sole power to vote these shares, and Latterell, the managing member of GP III, may be deemed to have shared power to vote these shares.

 

6

SHARED VOTING POWER
See response to row 5.

 

7

SOLE DISPOSITIVE POWER
36,821 shares, except that GP III, the general partner of Partners, may be deemed to have sole power to dispose of these shares, and Latterell, the managing member of GP III, may be deemed to have shared power to dispose of these shares.

 

8

SHARED DISPOSITIVE POWER
See response to row 7.

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

36,821

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 [_]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0.24%

12

TYPE OF REPORTING PERSON

PN

       

 

 

 

CUSIP #30049G104 Page 5 of 12

 

1

NAME OF REPORTING PERSONS

LVP GP III, LLC (“GP III”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) [_] (b) [X]

3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH
5

SOLE VOTING POWER
1,583,329 shares, of which 1,472,867 are directly owned by LVP III, 73,641 of which are directly owned by Associates and 36,821 of which are directly owned by Partners. GP III, the general partner of LVP III, Associates and Partners, may be deemed to have sole power to vote these shares, and Latterell, the managing member of GP III, may be deemed to have shared power to vote these shares.

 

6

SHARED VOTING POWER
See response to row 5.

 

7

SOLE DISPOSITIVE POWER
1,583,329 shares, of which 1,472,867 are directly owned by LVP III, 73,641 of which are directly owned by Associates and 36,821 of which are directly owned by Partners. GP III, the general partner of LVP III, Associates and Partners, may be deemed to have sole power to dispose of these shares, and Latterell, the managing member of GP III, may be deemed to have shared power to dispose of these shares.

 

8

SHARED DISPOSITIVE POWER
See response to row 7.

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,583,329

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 [_]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

10.28%

12

TYPE OF REPORTING PERSON

OO

       

 

 

 

CUSIP #30049G104 Page 6 of 12

 

1

NAME OF REPORTING PERSONS

LVPMC, LLC (“LVPMC”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) [_] (b) [X]

3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH
5

SOLE VOTING POWER
5,250 shares. Latterell, the manager of LVPMC, may be deemed to have sole power to vote these shares.

 

6

SHARED VOTING POWER
See response to row 5.

 

7

SOLE DISPOSITIVE POWER
5,250 shares. Latterell, the manager of LVPMC, may be deemed to have shared power to dispose of these shares.

 

8

SHARED DISPOSITIVE POWER
See response to row 7.

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

5,250

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

[_]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0.02%

12

TYPE OF REPORTING PERSON

OO

       
 

 

CUSIP #30049G104 Page 7 of 12

 

1

NAME OF REPORTING PERSONS

Patrick F. Latterell (“Latterell”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) [_] (b) [X]

3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH
5

SOLE VOTING POWER
5,250 shares, all of which are directly owned by LVPMC, LLC. Latterell is the manager of LVPMC, LLC and may be deemed to have sole power to vote those shares.

 

6

SHARED VOTING POWER
1,583,329 shares, of which 1,472,867 are directly owned by LVP III, 73,641 of which are directly owned by Associates and 36,821 of which are directly owned by Partners. Latterell is the managing member of GP III, which is the general partner of LVP III, Associates and Partners. Latterell may be deemed to have shared power to vote these shares.

 

7

SOLE DISPOSITIVE POWER
5,250 shares, all of which are directly owned by LVPMC, LLC. Latterell is the manager of LVPMC, LLC and may be deemed to have sole power to dispose of those shares.

 

8

SHARED DISPOSITIVE POWER
1,583,329 shares, of which 1,472,867 are directly owned by LVP III, 73,641 of which are directly owned by Associates and 36,821 of which are directly owned by Partners. Latterell is the managing member of GP III, which is the general partner of LVP III, Associates and Partners.  Latterell may be deemed to have shared power to dispose of these shares.

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,588,579

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 [_]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

10.28%

12 TYPE OF REPORTING PERSON IN
       
 

 

CUSIP #30049G104 Page 8 of 12

 

ITEM 1(A).NAME OF ISSUER

 

Evoke Pharma, Inc. (the “Issuer”)

 

ITEM 1(B).ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES

505 Lomas SantaFe Drive, Suite 270

Solana Beach, CA 92075

 

ITEM 2(A).NAME OF PERSONS FILING

This Schedule is filed by LVP Life Science Ventures III, L.P., a Delaware limited partnership, LVP III Associates, L.P., a Delaware limited partnership (“Associates”), LVP III Partners, L.P., a Delaware limited partnership (“Partners”), LVP GP III, LLC, a Delaware limited liability company (“GP III”), and Patrick Latterell (“Latterell”). The foregoing entities and individuals are collectively referred to as the “Reporting Persons.”

 

ITEM 2(B).ADDRESS OF PRINCIPAL OFFICE

 

The address for each of the Reporting Persons is:

 

c/o LVPMC, LLC

2603 Camino Ramon, Suite 200

San Ramon, CA 94583

ITEM 2(C).CITIZENSHIP

See Row 4 of cover page for each Reporting Person.

 

ITEM 2(D).TITLE OF CLASS OF SECURITIES

Common Stock, $0.0001 par value

 

ITEM 2(D)CUSIP NUMBER

30049G104

 

ITEM 3.If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

Not applicable.

 

ITEM 4.OWNERSHIP

 

The following information with respect to the ownership of the ordinary shares of the Issuer by the persons filing this Statement is provided as of December 31, 2017:

 

(a)Amount beneficially owned:

See Row 9 of cover page for each Reporting Person.

 

(b)Percent of Class:

See Row 11 of cover page for each Reporting Person.

 

 

   

 

CUSIP #30049G104 Page 9 of 12

 

(c)Number of shares as to which such person has:

 

(i)Sole power to vote or to direct the vote:

See Row 5 of cover page for each Reporting Person.

 

(ii)Shared power to vote or to direct the vote:

 

See Row 6 of cover page for each Reporting Person.

 

(iii)Sole power to dispose or to direct the disposition of:

 

See Row 7 of cover page for each Reporting Person.

 

(iv)Shared power to dispose or to direct the disposition of:

See Row 8 of cover page for each Reporting Person.

 

ITEM 5.OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

Not applicable.

 

ITEM 6.OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

Under certain circumstances set forth in the limited partnership agreements of LVP III, Associates and Partners and the limited liability company agreement of GP III, the partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from the sale of, shares of the Issuer owned by each such entity of which they are a partner or member.

 

ITEM 7.IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

Not applicable.

 

ITEM 8.IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

Not applicable

 

ITEM 9.NOTICE OF DISSOLUTION OF GROUP.

Not applicable

 

ITEM 10.CERTIFICATION.

Not applicable

 

   

 

CUSIP #30049G104 Page 10 of 12

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: January 12, 2018

 

  LVP LIFE SCIENCE VENTURES III, L.P.
   
  By:   LVP GP III, LLC
  Its:   General Partner
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell
  Its:   Managing Member
   
   
  LVP III ASSOCIATES, L.P.
   
  By:   LVP GP III, LLC
  Its:   General Partner
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell
  Its:   Managing Member
   
   
  LVP III PARTNERS, L.P.,
   
  By:   LVP GP III, LLC
  Its:   General Partner
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell
  Its:   Managing Member
   
   
  LVP GP III, LLC
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell
  Its:   Managing Member
   
   
  LVPMC, LLC
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell
  Its:   Manager
   
   
  PATRICK F. LATTERELL
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell

 

 

 

   

 

CUSIP #30049G104 Page 11 of 12

 

EXHIBIT INDEX

  Found on Sequentially
Exhibit Numbered Page
Exhibit A:  Agreement of Joint Filing 12
   

 

 

 

 

 

 

 

 

 

 

 

   

 

CUSIP #30049G104 Page 12 of 12

 

exhibit A

 

Agreement of Joint Filing

 

The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the common stock of the Issuer shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.

 

Date: January 12, 2018

 

 

  LVP LIFE SCIENCE VENTURES III, L.P.
   
  By:   LVP GP III, LLC
  Its:   General Partner
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell
  Its:   Managing Member
   
   
  LVP III ASSOCIATES, L.P.
   
  By:   LVP GP III, LLC
  Its:   General Partner
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell
  Its:   Managing Member
   
   
  LVP III PARTNERS, L.P.,
   
  By:   LVP GP III, LLC
  Its:   General Partner
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell
  Its:   Managing Member
   
   
  LVP GP III, LLC
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell
  Its:   Managing Member
   
   
  LVPMC, LLC
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell
  Its:   Manager
   
   
  PATRICK F. LATTERELL
   
  By:   /s/ Patrick F. Latterell
  Name:   Patrick F. Latterell